参考文献/References:
[1] 吴珊珊, 段振华. 强直性脊柱炎流行病学研究进展[J]. 安徽医科大学学报, 2013,48(8):988-992.
[2] 郑虹. 辨证分型从肾论治强直性脊柱炎的体会[J]. 中国中医骨伤科杂志, 2013,21(1):57-58.
[3] 葛均波, 徐永健. 内科学 [M]. 8版. 北京: 人民卫生出版社, 2013:823.
[4] 国家食品药品监督管理局. 中药新药临床研究指导原则 [M]. 北京: 中国医药科技出版社, 2002:120-122.
[5] 孙志岭, 王玲, 王富强, 等. 类风湿关节炎肝肾阴虚证血清比较蛋白质组学分析[J]. 中华中医药杂志, 2013,28(10):3079-3081.
[6] Rosado MM, Bennici E, Novelli F, et al. Beyond DNA repair, the immunological role of parp-1 and its siblings[J]. Immunology, 2013,139(4):428-437.
[7] Ba X, Garg NJ. Signaling mechanism of poly(adp-ribose)polymerase-1(parp-1)in inflammatory diseases[J]. The American Journal of Pathology, 2011,178(3):946-955.
[8] Kibirev VK, Osadchuk TV, Radavskii IL.Furin and its biological role[J]. Ukrainskii Biokhimicheskii Zhurnal, 2007,79(6):5-18.
[9] Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease[J]. Nat Revi Mol Cell Biol, 2002,3(10):753-766.
[10] Gu Y, Lu C, Zha Q, et al. Plasma metabonomics study of rheumatoid arthritis and its chinese medicine subtypes by using liquid chromatography and gas chromatography coupled with mass spectrometry[J]. Molecular BioSystems, 2012,8(5):1535-1543.
[11] Dejana E, Vestweber D. The role of ve-cadherin in vascular morphogenesis and permeability control[J]. Prog in Mol Biol Transl, 2013,116:119-144.
[12] Gavard J. Endothelial permeability and ve-cadherin: a wacky comradeship[J]. Cell Adh Migr, 2013,7(6):455-461.
[13] 周丽伟, 马飞, 李庆伟. 激肽原基因的选择性剪接与功能研究进展[J]. 遗传, 2006,28(12):1649-1655.
[14] 白怀, 刘瑞. 血管紧张素原研究进展[J]. 国外医学:临床生物化学与检验学分册, 1999,20(6):246-248.
[15] 肖红丽, 王艳, 孙芳芳, 等. 血管紧张素-(1-7)的生物学作用及其信号通路进展[J]. 医学综述, 2010,16(9):1287-1290.